España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Lipocine
LPCN
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$4.76
0.04
0.85%
At close: -
$4.72
-0.04
-0.84%
After Hours: Dec 27, 8:00 AM EDT
Get Report
Comment
Lipocine (LPCN) Forecast
News
Earnings
Lipocine (LPCN) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Lipocine (NASDAQ:LPCN) Stock
Lipocine Stock (NASDAQ: LPCN)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Tuesday, December 17, 2024
FDA Grants Fast Track Designation To Lipocine...
Benzinga Newsdesk
Monday, November 18, 2024
Lipocine Announces The Publication And Discus...
Benzinga Newsdesk
Thursday, November 07, 2024
Lipocine shares are trading lower. The compan...
Benzinga Newsdesk
Lipocine Q3 EPS $(0.44) Beats $(0.48) Estimat...
Benzinga Newsdesk
Thursday, October 31, 2024
Lipocine Announces Distribution And License A...
Benzinga Newsdesk
Thursday, October 10, 2024
Lipocine Reports Data From Its qEEG Study Of ...
Benzinga Newsdesk
Lipocine Announced Oral Brexanolone QEEG Resu...
Benzinga Newsdesk
Tuesday, October 08, 2024
Lipocine Announces Supply And Distribution Ag...
Benzinga Newsdesk
Tuesday, September 24, 2024
Alliance Global Partners Initiates Coverage O...
Benzinga Newsdesk
Thursday, September 05, 2024
Lipocine Announces Phase 2 Data On LPCN 2401 ...
Benzinga Newsdesk
Thursday, August 08, 2024
Lipocine Q2 2024 GAAP EPS $(0.56) Beats $(0.7...
Benzinga Newsdesk
Tuesday, June 25, 2024
Lipocine Says LPCN 1154 Met standard Bioequiv...
Benzinga Newsdesk
Wednesday, June 19, 2024
12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga Insights
Monday, June 10, 2024
Lipocine To Present 52 Week Results From LPCN...
Benzinga Newsdesk
Thursday, May 09, 2024
Lipocine Q1 EPS $0.66 Up From $(0.76) YoY, Sa...
Benzinga Newsdesk
Wednesday, May 08, 2024
Lipocine Announces Late Breaking Oral Present...
Benzinga Newsdesk
Wednesday, May 01, 2024
Lipocine Announces Completion Of Dosing In Pi...
Benzinga Newsdesk
Thursday, April 11, 2024
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga Insights
Lipocine shares are trading higher after the ...
Benzinga Newsdesk
Lipocine Announced Results From A Phase 2 Tri...
Benzinga Newsdesk
Thursday, March 28, 2024
Lipocine Announces Week 52 Results From LPCN ...
Benzinga Newsdesk
Monday, March 25, 2024
Lipocine Announces First Cohort Dosed in Pivo...
Benzinga Newsdesk
Wednesday, March 13, 2024
12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga Insights
Tuesday, February 06, 2024
Lipocine Announces Confirmation Of Dosing Reg...
Benzinga Newsdesk
Thursday, January 18, 2024
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga Insights
Lipocine And Verity Pharma Enter Into License...
Benzinga Newsdesk
Monday, November 13, 2023
Lipocine Releases Late Breaking Presentation ...
Benzinga Newsdesk
Friday, October 06, 2023
Lipocine Received Notice From Antares Of Anta...
Benzinga Newsdesk
Thursday, September 28, 2023
Stocks That Hit 52-Week Lows On Thursday
Benzinga Insights
Wednesday, August 16, 2023
Watching Lipocine Inc.; Zacks Small-Cap Research Sets $40 Price Valuation
Happy Mohamed
Thursday, August 10, 2023
Lipocine Q2 EPS $(0.68) Misses $(0.64) Estima...
Benzinga Newsdesk
Thursday, July 27, 2023
Why Willis Towers Watson Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Lisa Levin
Why Lipocine Stock Is Moving Higher Today?
Vandana Singh
Cantor Fitzgerald Reiterates Overweight on Li...
Benzinga Newsdesk
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga Insights
Market-Moving News for July 27th
Benzinga Newsdesk
Lipocine shares are trading higher after the ...
Benzinga Newsdesk
Lipocine Announced Topline Results From A Pha...
Benzinga Newsdesk
Friday, May 19, 2023
Watching Lipocine; Zacks Small-Cap Research S...
Benzinga Newsdesk
Tuesday, May 16, 2023
Stocks That Hit 52-Week Lows On Tuesday
Benzinga Insights
Lipocine Announced Topline Results From A Pil...
Benzinga Newsdesk
Thursday, May 11, 2023
Why Groupon Shares Are Trading Lower By 22%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Lisa Levin
Lipocine Says On May 10 Board Approved 1-For-...
Benzinga Newsdesk
Recap: Lipocine Q1 Earnings
Benzinga Insights
Lipocine Q1 EPS $(0.04) Misses $(0.02) Estima...
Benzinga Newsdesk
Friday, May 05, 2023
Stocks That Hit 52-Week Lows On Friday
Benzinga Insights
Tuesday, April 04, 2023
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga Insights
Why AMC Entertainment Holdings Shares Are Trading Lower By 25%; Here Are 20 Stocks Moving Premarket
Lisa Levin
Monday, April 03, 2023
Lipocine Said First Participant Has Been Dosed In Pilot Clinical Bridge Study Of LPCN 1154 And Approved Injectable Brexanolone; Topline Study Results Expected In H1 2023
Charles Gross
Monday, March 27, 2023
Around $3M Bet On This Basic Materials Stock? Check Out These 4 Penny Stocks Insiders Are Buying
Lisa Levin
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch